Original
Consecuencias clínicas y económicas de la combinación de metformina con inhibidores de la dipeptidilpeptidasa en pacientes con diabetes tipo 2
Clinical and economical consequences of the combination of metformin with dipeptidyl peptidase inhibitors in type 2 diabetes patients
a Dirección de planificación, Badalona Serveis Assistencials SA, Badalona, Barcelona, España
b Novartis Farmacéutica SA, Barcelona, España
c Documentación médica, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
d Dirección médica, Badalona Serveis Assistencials SA, Badalona, Barcelona, España
Leído
1584
Vecesse ha leído el artículo
474
Total PDF
1110
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 3 | 0 | 3 |
| 2025 5 | 66 | 10 | 76 |
| 2025 4 | 57 | 6 | 63 |
| 2025 3 | 33 | 5 | 38 |
| 2025 2 | 25 | 1 | 26 |
| 2025 1 | 19 | 1 | 20 |
| 2024 12 | 17 | 0 | 17 |
| 2024 11 | 12 | 1 | 13 |
| 2024 10 | 18 | 0 | 18 |
| 2024 9 | 16 | 1 | 17 |
| 2024 8 | 17 | 2 | 19 |
| 2024 7 | 11 | 2 | 13 |
| 2024 6 | 10 | 4 | 14 |
| 2024 5 | 10 | 1 | 11 |
| 2024 4 | 12 | 1 | 13 |
| 2024 3 | 12 | 4 | 16 |
| 2024 2 | 9 | 1 | 10 |
| 2024 1 | 10 | 3 | 13 |
| 2023 12 | 11 | 0 | 11 |
| 2023 11 | 20 | 4 | 24 |
| 2023 10 | 10 | 3 | 13 |
| 2023 9 | 18 | 1 | 19 |
| 2023 8 | 7 | 0 | 7 |
| 2023 7 | 12 | 5 | 17 |
| 2023 6 | 12 | 13 | 25 |
| 2023 5 | 17 | 0 | 17 |
| 2023 4 | 9 | 2 | 11 |
| 2023 3 | 13 | 6 | 19 |
| 2023 2 | 6 | 0 | 6 |
| 2022 1 | 11 | 1 | 12 |
| 2022 12 | 8 | 1 | 9 |
| 2022 11 | 14 | 1 | 15 |
| 2022 10 | 16 | 3 | 19 |
| 2022 9 | 10 | 2 | 12 |
| 2022 8 | 13 | 4 | 17 |
| 2022 7 | 14 | 3 | 17 |
| 2022 6 | 8 | 1 | 9 |
| 2022 5 | 15 | 7 | 22 |
| 2022 4 | 11 | 6 | 17 |
| 2022 3 | 20 | 2 | 22 |
| 2022 2 | 10 | 3 | 13 |
| 2021 1 | 8 | 1 | 9 |
| 2021 12 | 6 | 3 | 9 |
| 2021 11 | 4 | 4 | 8 |
| 2021 10 | 0 | 1 | 1 |
| 2021 9 | 0 | 2 | 2 |
| 2021 8 | 0 | 1 | 1 |
| 2021 6 | 0 | 3 | 3 |
| 2021 4 | 0 | 2 | 2 |
| 2021 3 | 0 | 6 | 6 |
| 2020 1 | 0 | 1 | 1 |
| 2020 12 | 0 | 1 | 1 |
| 2020 11 | 0 | 1 | 1 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 0 | 1 | 1 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 5 | 5 |
| 2020 4 | 0 | 5 | 5 |
| 2020 3 | 0 | 3 | 3 |
| 2020 2 | 0 | 2 | 2 |
| 2020 1 | 0 | 4 | 4 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 0 | 1 | 1 |
| 2019 8 | 0 | 2 | 2 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 0 | 16 | 16 |
| 2019 5 | 0 | 11 | 11 |
| 2019 4 | 0 | 16 | 16 |
| 2019 3 | 0 | 3 | 3 |
| 2019 2 | 0 | 10 | 10 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 0 | 5 | 5 |
| 2018 8 | 0 | 1 | 1 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 0 | 4 | 4 |
| 2018 5 | 0 | 2 | 2 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 25 | 4 | 29 |
| 2018 1 | 21 | 4 | 25 |
| 2017 12 | 15 | 4 | 19 |
| 2017 11 | 27 | 10 | 37 |
| 2017 10 | 18 | 13 | 31 |
| 2017 9 | 19 | 5 | 24 |
| 2017 8 | 7 | 9 | 16 |
| 2017 7 | 7 | 4 | 11 |
| 2017 6 | 14 | 8 | 22 |
| 2017 5 | 17 | 5 | 22 |
| 2017 4 | 18 | 7 | 25 |
| 2017 3 | 20 | 17 | 37 |
| 2017 2 | 6 | 6 | 12 |
| 2016 1 | 9 | 2 | 11 |
| 2016 12 | 43 | 13 | 56 |
| 2016 11 | 35 | 19 | 54 |
| 2016 10 | 40 | 15 | 55 |
| 2016 9 | 31 | 12 | 43 |
| 2016 8 | 42 | 13 | 55 |
| 2016 7 | 18 | 8 | 26 |
| 2016 6 | 0 | 16 | 16 |
| 2016 2 | 0 | 2 | 2 |
| 2015 12 | 1 | 6 | 7 |
| 2015 11 | 4 | 10 | 14 |
| 2015 10 | 0 | 1 | 1 |
| 2015 9 | 0 | 1 | 1 |
| 2015 8 | 0 | 1 | 1 |
| 2015 6 | 0 | 1 | 1 |
| 2015 4 | 0 | 1 | 1 |
| 2015 3 | 0 | 1 | 1 |
| 2015 2 | 1 | 3 | 4 |
| 2015 1 | 1 | 0 | 1 |
| 2014 12 | 1 | 1 | 2 |
| 2014 11 | 1 | 1 | 2 |
| 2014 10 | 1 | 1 | 2 |
| 2014 9 | 1 | 1 | 2 |
| 2014 8 | 2 | 1 | 3 |
| 2014 7 | 1 | 1 | 2 |
| 2014 6 | 2 | 2 | 4 |
| 2014 5 | 2 | 1 | 3 |
Mostrar todo
